1. Tominaga M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Takeshima T & Kikkawa T (2009) Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan : Findings from the World Mental Health Japan Survey 2002-2004. Social Psychiatry and Psychiatric Epidemiology, 44, 777-783.
2. Omori IM, Watanabe N, Nakagawa A, Akechi T, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (2009) Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. Journal of Psychopharmacoogy, 23, 539-550.
3. Furukawa TA, Katherine Shear M, Barlow DH, Gorman JM, Woods SW, Money R, Etschel E, Engel RR & Leucht S (2009) Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale. Depression and Anxiety, 26, 922-929.
   
4. Furukawa TA (2009) A stepped-care prevention programme decreased depression and anxiety disorders in elderly patients. Evidence-Based Medicine, 14, 146.
5. Azuma H, Segawa K, Nakaaki S, Murata Y, Kawakami K, Tohyama J, Iidaka T, Shinagawa Y, Nakano Y, Yamada A, Watanabe N, Hongo J, Akechi T & Furukawa TA (2009) Neural correlates of memory in depression measured by brain perfusion SPECT at rest. Psychiatry and Clinical Neurosciences, 63, 685-692.
6. Yamanishi T, Nakaaki S, Omori IM, Hashimoto N, Shinagawa Y, Hongo J, Horikoshi M, Tohyama J, Akechi T, Soma T, Iidaka T & Furukawa TA (2009) Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder. Psychiatry Research, 172, 242-250.
   
7. Tatsumi H, Nakaaki S, Torii K, Shinagawa Y, Watanabe N, Murata Y, Sato J, Mimura M & Furukawa TA (2009) Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: a two-year follow-up study. Psychiatry and Clinical Neurosciences, 63, 374-384.
   
8. Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R & Furukawa TA (2009) Milnacipran versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006529.
9. Okuyama T, Endo C, Seto T, Kato M, Seki N, Akechi T, Furukawa TA, Eguchi K & Hosaka T (2009) Cancer patients' reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: a preliminary study. Palliative and Supportive Care, 7, 229-233.
   
10. Sasaki M, Kataoka-Higashiguchi K, Morikawa Y, Nakagawa H (2009) Relationship between stress coping and burnout in Japanese hospital nurses. Journal of Nursing Management, 17, 359-365.
11. Omori IM & Wang J (2009) Sulpiride versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, CD007811.
12. Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R & Barbui C (2009) Escitalopram versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006532.
13. Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H & Barbui C (2009) Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006117.
14. Cipriani A, Geddes JR, Furukawa TA, Salanti G & Barbui C (2009) Ranking antidepressants -- Authors' reply. Lancet, 373, 1761-1762.
15. Akechi T, Ietsugu T, Sukigara M, Okamura H, Nakano T, Akizuki N, Okamura M, Shimizu K, Okuyama T, Furukawa TA & Uchitomi Y (2009) Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria. General Hospital Psychiatry, 31, 225-232.
    
16. Elamin MB, Flynn DN, Bassler D, Briel M, Alonso-Coello P, Karanicolas PJ, Guyatt GH, Malaga G, Furukawa TA, Kunz R, Schunemann H, Murad MH, Barbui C, Cipriani A & Montori VM (2009) Choice of data extraction tools for systematic reviews depends on resources and review complexity. Journal of Clinical Epidemiology, 62, 506-510.
    
17. Furukawa TA, Chen J, Watanabe N, Nakano Y, Ietsugu T, Ogawa S, Funayama T & Noda Y (2009) Videotaped experiments to drop safety behaviors and self-focused attention for patients with social anxiety disorder: Do they change subjective and objective evaluations of anxiety and performance? Journal of Behavior Therapy and Experimental Psychiatry, 40, 202-210.
    
18. Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R & Barbui C (2009) Escitalopram versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006532.
19. Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H & Barbui C (2009) Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006117.
    
20. Watanabe N, Churchill R & Furukawa TA (2009) Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database of Systematic Reviews, CD005335.
21. Tsuchiya M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Takeshima T, Kikkawa T & Kessler RC (2009) Lifetime comorbidities between phobic disorders and major depression in Japan: results from the World Mental Health Japan 2002-2004 Survey. Depression and Anxiety.
22. Sagawa R, Akechi T, Okuyama T, Uchida M & Furukawa TA (2009) Etiologies of delirium and their relationship to reversibility and motor subtype in cancer patients. Japanese Journal of Clinical Oncology, 39, 175-182.
23. Okuyama T, Akechi T, Yamashita H, Toyama T, Endo C, Sagawa R, Uchida M & Furukawa TA (2009) Reliability and validity of the Japanese version of the Short-form Supportive Care Needs Survey Questionnaire (SCNS-SF34-J). Psycho-Oncology.
24. Kinoshita Y, Tsuchiya M, Kawakami N, Furukawa TA & Kingdon D (2009) Hallucinations in visually impaired individuals : An analysis of the National Comorbidity Survey Replication. Social Psychiatry and Psychiatric Epidemiology, 44, 104-108.
25. Furukawa TA, Yoshimura R, Harai H, Imaizumi T, Takeuchi H, Kitamura T & Takahashi K (2009) How many well vs. unwell days can you expect over 10 years, once you become depressed? Acta Psychiatrica Scandinavica, 119, 290-297.
26. Faravelli C, Furukawa TA & Truglia E (2009) Panic disorder. In Stress-Induced and Fear Circuitry Disorders: Refining the Research Agenda for DSM-V. (eds Andrews G, Charney DS, Sirovatka PJ & Regier DA), pp. 31-58. Washington, D.C.: American Psychiatric Association.
27. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M & Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 373, 746-758.Paper that changed our practices
    
28. Chen J, Tsuchiya M, Kawakami N & Furukawa TA (2009) Non-fearful vs fearful panic attacks: A general population study from the National Comorbidity Survey. Journal of Affective Disorders, 112, 273-278.
29. Akechi T, Okamura H, Okuyama T, Furukawa TA, Nishiwaki Y & Uchitomi Y (2009) Psychosocial factors and survival after diagnosis of inoperable non-small cell lung cancer. Psycho-Oncology, 18, 23-29.